TABLE 4

Number and proportion of treatment regimens prescribed for a cohort of US hospital-based laboratory-confirmed Mycobacterium avium complex patients, by provider- and facility-level factors, among those encounters receiving treatment

SubjectsGuidelines basedResistance associatedOther
Size of facility (number of beds)
 <20011818 (15)42 (36)58 (49)
 200–49943474 (17)144 (33)216 (50)
 ≥50028660 (21)60 (21)#,¶166 (58)
Teaching status
 Yes48087 (18)149 (31)244 (51)
 No35865 (18)97 (27)196 (55)
Setting of facility
 Rural4410 (23)8 (18)26 (59)
 Urban794142 (18)238 (30)414 (52)
Region of facility
 Midwest18520 (11)53 (29)112 (61)
 Northeast22430 (13)94 (42)#100 (45)#
 South29570 (24)#,¶70 (24)155 (53)
 West13432 (24)#,¶26 (22)73 (54)
Specialty of attending physician
 Internal medicine32671 (22)93 (29)162 (50)
 Pulmonology7815 (19)19 (24)44 (56)
 Hospitalists20829 (14)#70 (34)109 (52)
 Other22637 (16)64 (28)125 (55)

Data are presented as n or n (%). Significance p≤0.05. #: significantly different from category 1; : significantly different from category 2.